Skip to main content
Accueil
  • fr
  • en

Main navigation

  • Company
    • Company profile
    • Management
    • Our history
    • Great Place to Work
  • Science
    • Scientific approach
    • Innate Immunity & NK cells
    • Antibody formats
    • Publications
  • Products
    • Pipeline overview
    • Clinical trials
    • ------------------
    • Lacutamab
    • Monalizumab
    • Avdoralimab
    • IPH5201
    • IPH5301
    • IPH6101
    • IPH62
    • ------------------
    • LUMOXITI
  • Partnering
  • Investors
  • Media
    • Media hub
    • All press releases
    • Media center
  • Careers

Media Hub

  1. Home
  2. Media

Latest Press Releases

  • Innate's first NK cell engager selected by Sanofi as drug candidate for development

    January 5, 2021
  • Innate Pharma to participate in upcoming investor conferences

    January 4, 2021
  • Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZeneca

    December 11, 2020

Selected media

  • IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier

    Tue, 06/23/2020 - 10:45
    • Read more about IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier
  • Avdoralimab in COVID-19

    Tue, 04/28/2020 - 12:15
    • Read more about Avdoralimab in COVID-19
  • Nasdaq #BehindTheBell (October 17, 2019)

    Wed, 10/30/2019 - 09:45
    • Read more about Nasdaq #BehindTheBell (October 17, 2019)

Main menu

  • Media hub
  • All press releases
  • Media center
    • 20th Anniversary

Tweets by InnatePharma

Media contact details

Tracy Rossin (Global / US)

Tracy.Rossin@innate-pharma.com

Dana Cormack (US)

dana.cormack@innate-pharma.com

 

   

 

 

Footer

  • Contact
  • Location
  • Legal Info
  • Terms of use
  • Privacy Notice
  • Cookies notice

Follow us

   

Stay in touch

 Subscribe to our newsletter

 Contact us
 

Location

117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

 +33 (0)4 30 30 30 30

 Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Innate Pharma